baber/WOPTO huggingface dataset:
Patent NZ-528594-A (NZ)
Title: Methods using O6-alkylguanine-DNA alkyltransferases
Inventor: JOHNSSON KAI
IPC: G01N33/543
Filed: 2002-04-05
Abstract: A method using O6-alkylguanine-DNA alkyltransferases (AGT) is disclosed for transferring a label from a substrate to a fusion protein comprising the AGT. This allows the detection and/or manipulating of the fusion protein, by attaching molecules to the fusion proteins that introduce a new physical or chemical property to the fusion protein. Examples of such molecules are, among others, spectroscopic probes or reporter molecules, affinity tags, molecules generating reactive radicals, cross-linkers, ligands mediating protein-protein interactions or molecules suitable for the immobilisation of the fusion protein.
Patent NZ-528721-A (NZ)
Title: Antimicrobial compositions formulated for use in cold temperature conditions and methods of use thereof
Inventor: REINHARDT DUANE JOSEPH
IPC: A61K31/20
Filed: 2001-10-01
Abstract: An anti-microbial composition comprising: in the range of 0.01% to 5 wt.% of heptanoic acid; and greater than 60 wt.% of a freezing point depressant component comprising propylene glycol and glycerin.
Patent NZ-531397-A (NZ)
Title: Audio amplifier circuit for producing distortion effects
Inventor: POLETTI MARK ALISTAIR
IPC: G10H1/00
Filed: 2004-02-26
Abstract: A musical instrument amplifier circuit for distorting an audio input signal comprising an amplifier that receives the input signal and generates an audio output signal according to a transfer characteristic that demonstrates a substantially gradual transition between linear and non-linear behaviour, and a filter to filter the output signal having at least a low-pass characteristic and following the amplifier. A negative feedback loop is arranged to feed the output signal back into the input signal to provide a sufficiently wide small-signal bandwidth at lower input signal voltages to produce a substantially undistorted output signal, the small-signal bandwidth reducing as the input signal voltage increases, driving the amplifier into non-linear behaviour to produce a distorted output signal that has reduced high frequency products. One embodiment comprises multiple such amplifier circuits each receiving one of multiple frequency band signals from an equi-phase bandsplitter and outputting a signal to a summing device which recombines the multiple output signals into a single audio output signal that has reduced intermodulation distortion.
Patent NZ-532893-A (NZ)
Title: Elevator with a belt-like transmission means, especially with a V-ribbed belt, serving as supporting and/or drive means
Inventor: ACH ERNST FRIEDRICH
IPC: B66B11/00
Filed: 2002-11-20
Abstract: A wedge-ribbed belt supports an elevator car by underlooping and engages a drive pulley of a drive mounted at the head of an elevator shaft. The belt has a running surface facing the drive pulley with a plurality of ribs and grooves extending in parallel in a longitudinal direction of the belt. The ribs and grooves can be triangular-shaped or trapezium- shaped in cross section. A plane of the drive pulley is arranged vertically and at right angles to a car wall at a counterweight side of the elevator car and approximately in a middle of a car depth with a vertical projection of the drive pulley onto the counterweight side being outside a vertical projection of the counterweight side. A part of a vertical projection of the drive motor is superimposed on the vertical projection of the counterweight side of the elevator car.
Patent NZ-534594-A (NZ)
Title: Impact modifier compositions for rigid PVC compositions of hydrocarbon rubbers and chlorinated polyethylene
Inventor: HATA NOBUHIRO
IPC: C08L27/06
Filed: 2003-01-16
Abstract: Polyvinyl chloride composition having excellent impact strength are disclosed, wherein this impact resistant composition comprises a vinyl chloride polymer and 2-8 parts of an impact modifier composition comprising at least one ethylene/alpha-olefin copolymer and at least one chlorinated olefin polymer per 100 parts of the vinyl chloride polymer, wherein the impact modifier composition comprises less than 1 part of the ethylene/alpha-olefin copolymer and the ratio of ethylene/alpha-olefin copolymer to the total modifier composition is less than 25%.
Patent NZ-535693-A (NZ)
Title: Method and apparatus for making capsules
Inventor: DRAISEY ALLAN
IPC: B29C65/04
Filed: 2003-04-01
Abstract: Capsules, for example for the delivery of pharmaceuticals, are produced from two films ( 18 ) of a water-soluble polymeric material, by deforming the films to form a multiplicity of recesses, and filling the recesses, using two adjacent rotary dies ( 14, 15; 42 ) with recesses ( 16 ) into which the films ( 18 ) are deformed. The dies (14, 15; 42) act as electrodes for welding the films together by dielectric welding to form filled capsules (30). The capsules ( 30 ) can be separated from the resulting web either by coating at least one of the dies ( 14 ) with an electrical insulator ( 21 ), or by transferring the web from the dies ( 14, 15; 42 ) to a second pair of dies which cut the capsules ( 30 ) free. The polymeric material may be gelatine, or a water-soluble cellulose derivative such as hydroxypropyl methyl cellulose, and may also contain a plasticizer.
Patent NZ-536133-A (NZ)
Title: Valve
Inventor: JOBE DAVID
Filed: 2004-10-26
Abstract: A valve for controlling liquid level in a reservoir that may be quickly mounted and demounted to allow for simplified installation and maintenance is disclosed. The valve body 20, 21 has an inlet 40 and an outlet 5 for directing water into the reservoir. An adaptor 1 with a valve seating face is mated to a threaded fitting at one end and is configured to be readily demountable to the valve body inlet 40 at the other end. A pressure responsive member 29 is moveable in response to variations in control pressure in a control chamber 32. The pressure responsive member has a valve surface for sealing against the valve seating face of the adaptor to stop the flow of water from the inlet to the outlet. The valve assembly is able to demounted from the adapter as a single unit.
Patent NZ-537584-A (NZ)
Title: 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
Inventor: MEHTA ANITA
IPC: A61P3/04
Filed: 2002-07-08
Abstract: Disclosed herein are derivatives of 3,6 disubstituted azabicyclo[3.1.0] hexanes of formula (I) and pharmaceutical compositions thereof, wherein the substituents for the variables are as defined in the specification. These compounds are muscarinic receptor antagonists which are useful, inter-alia for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors.
Patent NZ-543470-A (NZ)
Title: Security device for use in a pilot circuit of a hydraulic machine including a rod which is rotated by an appropriately shaped key
Inventor: MCKAY WAYNE PAUL
IPC: B60R25/00
Filed: 2005-11-08
Abstract: A security device 1, for installation in a pilot circuit of a hydraulically operated machine, comprises a housing 2 containing a cavity 3 and a head 4. The head 4, when rotated, switches the device 1 between at least two modes of operation. The top of the head 4 is recessed into the cavity 3 at a depth below a rim of the cavity 3, and a wall of the cavity 3 is positioned in sufficient proximity to an external side of the head 4 such that rotation of the head 4 requires application of a key which engages with the external side of the head 4.
Patent NZ-543916-A (NZ)
Title: Fragrance delivery system
Inventor: ATENCIA TONI BRONCANO
Filed: 2005-12-02
Abstract: A system for delivering at least two different fragrances is disclosed. A release mechanism is controlled by a control unit to release a fragrance selected from a set of at least two fragrances. The control unit randomly selects the fragrance in response to the system being turned on. Further embodiments include the release mechanism switching between first and second states, where the fragrance delivery rate is higher in the first state than in the second state.
Patent NZ-546711-A (NZ)
Title: Immunisation against chlamydia trachomatis
Inventor: GRANDI GUIDO
IPC: A61K48/00
Filed: 2002-12-12
Abstract: Disclosed is the use of a protein comprising an amino acid sequence set forth in SEQ ID NO:61 or a nucleic acid comprising a nucleotide sequence set forth in SEQ ID NO:62 in the manufacture of a medicament to neutralize Chlamydia infectivity. Also disclosed is the use of a fragment of at least 7 contiguous amino acids or nucleotides of the sequences above and an antibody that binds the protein to neutralize Chlamydia infectivity.
Patent NZ-549778-A (NZ)
Title: Combinations for treating HIV infection
Inventor: LIN PIN-FANG
IPC: A61K31/522
Filed: 2005-03-01
Abstract: Disclosed is the use, in the preparation of a pharmaceutical combination for treating HIV infection in a human patient, of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine, or a pharmaceutically acceptable salt or solvate thereof, and at least one other agent used for treatment of AIDS or HIV infection selected from the group consisting of nucleoside HIV reverse transcriptase inhibitors, non-nucleoside HIV reverse transcriptase inhibitors, HIV protease inhibitors and HIV fusion inhibitors, wherein the EC50 ratio of said piperazine compound to said other AIDS or HIV agent is 1:1, 1:2.5 or 2.5:1.
Patent NZ-552021-A (NZ)
Title: Retractable syringe with protective syringe carrier
Inventor: HARRISON NIGEL
IPC: A61M5/20
Filed: 2005-05-27
Abstract: An injection device 110 comprising a housing 112 adapted to receive a syringe 114 having a relatively wide reservoir portion 134 and a relatively narrow discharge nozzle 118, so that the syringe 114 is movable between a retracted position in which the discharge nozzle 118 is contained within the housing 112 and an extended position in which the discharge nozzle 118 extends from the housing 112 through an exit aperture 128, a drive element 140 that acts upon the syringe 114, a drive that acts upon the drive element 140 to advance the syringe 114 from its retracted position to its extended position and discharge its contents through the discharge nozzle 118, a syringe carrier for carrying the syringe 114 as it is advanced and restraining its advancement beyond its extended position, wherein the syringe carrier is adapted to support the syringe 114 between the reservoir portion 134 and the discharge nozzle 118, wherein the syringe carrier comprises a portion which is adapted to act as part of a release mechanism and couple with the drive element 140 in order to disconnect the drive element 140 from the drive.
Patent NZ-552440-A (NZ)
Title: Early-warning system comprising sodar for wind energy turbines
Inventor: WOBBEN ALOYS
IPC: F03D17/00
Filed: 2002-06-26
Abstract: An early-warning for protecting wind power installations in a wind park, comprising means, other than acoustic means, for measuring the wind conditions in the region of a first wind power installation, the measured data being processed by a control device which controls the first wind power installation and/or another second wind power installation in the proximity of the wind power installation. The control involves in particular adjustment of the angle of attack of a rotor blade with respect to the wind (pitch) and adjustment of the angle of attack is effected as soon as a wind condition endangering the first wind power installation is measured.
Patent NZ-564572-A (NZ)
Title: Integrated process for making inflatable article
Inventor: KANNANKERIL CHARLES
IPC: B29C48/305
Filed: 2002-08-22
Abstract: An integrated process for making an inflatable article includes extruding a tubular film 35, cooling the film so that the inside surface of the tube does not stick to itself, laying the film into a flat configuration 29 and heat sealing portions of the film to itself to make a sealed tubular film without thermoforming of the film. The heat sealing is performed by passing the tubular layed flat film in a partial wrap around a heated roller 16 having a raised surface, the heat sealing being carried out to provide a pattern of sealed and unsealed areas with the unsealed areas providing inflatable chambers between the inside surfaces of the sealed tubular film.
Patent NZ-566213-A (NZ)
Title: A medical use electrical lead including a radio opaque marker
Inventor: ANDERSON NEIL LAWRENCE
Filed: 2008-02-26
Abstract: A medical use electrical lead (10) is disclosed. The medical use electrical lead (10) includes an elongate body member having an inner tubular member (12), defining a lumen (16) and a cover member (20), covering the inner tubular member (14). At least one electrode is defined on an outer surface of the cover member (20) and at least one pair of conductors (18) is arranged between the inner tubular member (14) and the cover member (20). The conductors (18) are arranged to be in electrical communication with the electrode through the cover member (20). A radio opaque marker (28) circumscribes a periphery of the inner tubular member (14) and underlies the at least one electrode.
Patent NZ-576523-A (NZ)
Title: Use of modified cyclosporins
Inventor: KOHJIMA MOTOYUKI
IPC: A61P1/16
Filed: 2007-10-10
Abstract: Disclosed herein is the use of a cyclosporin in the preparation of a pharmaceutical composition for preventing or treating graft-cirrhosis, wherein the cyclosporin is a compound as given by formula Ia, in which the substituents are as defined within the specification.
Patent NZ-579564-A (NZ)
Title: Fluid driven generator with inner stator coil array and radially spaced blades
Inventor: HOSEGOOD DAVID
IPC: H02K3/00
Filed: 2010-11-26
Abstract: A wind or air fluid driven generator for producing electrical power, the fluid driven generator includes a base; a radial coiled array with a central opening; a magnetic hub in which the radial coiled array is situated within, the magnetic hub located in an outer housing that has equally circumferentially spaced vertical blades attached radially outwards from the housing, rotates relative to the radial coiled array; bearing means located between the internal surface of the central opening of the radial coiled array and a central portion of the magnetic hub. The blades, under the action of a gas passing over the blades, rotate around a central longitudinal or central horizontal axis of the fluid driven generator such that the blades rotationally drive the outer housing which in tum rotates the magnetic hub relative to the radial coiled array to produce electrical power. The generator can have a plurality of magnetic hubs and a matching number of radial coiled arrays.
Patent NZ-589823-A (NZ)
Title: Systems, methods, and software for retrieving information using multiple query languages
Inventor: BREI JAMES E
IPC: G06F17/30
Filed: 2006-01-13
Abstract: A method and a system for retrieving information utilizing a computer are disclosed. The system comprises a server; a client access device (110) interfacing with the server (230) through a network and providing a user query to the server; an application running on the server including means for receiving the user query; a language converter configured to convert the structure of the query into an abstract syntax tree to form a normalized query; means, responsive to a first translated version of the normalized query in a first query language, to identify documents in a first database; means, responsive to a second translated version of the normalized query in a second query language, the first query language being different than the second query language, to identify documents in a second database; and means for returning search results identifying documents from the first and second databases to the client access device.
Patent NZ-591073-A (NZ)
Title: Pyrrolidin-2-ones as hdm2 ligands
Inventor: KALINSKI CEDRIC
IPC: A61K31/4015
Filed: 2009-09-15
Abstract: Disclosed are substituted 2-pyrrolidone compounds of Formula (I), salts thereof, and methods for their preparation. Specific examples of compounds of Formula (I) include: (cis)-4-[1-(4-Bromo-benzyl)-2-(6-chloro-1H-indol-3-yl)-5-oxo-3-p-tolylsulfanyl-pyrrolidine-3-carbonyl]-piperazine-1-carboxylic acid ethylamide, cis-1-[(4-bromophenyl)methyl]-2-(6-chloro-1H-indol-3-yl)-3-[(4-ethylphenyl)sulfanyl]-N-[3-(morpholin-4-yl)propyl]-5-oxopyrrolidine-3-carboxamide, trans-1-[(4-chlorophenyl)methyl]-2-(6-fluoro-1H-indol-3-yl)-N-[3-(morpholin-4-yl)propyl]-5-oxo-3-(phenylsulfanyl)pyrrolidine-3-carboxamide, and cis-2-(6-chloro-1-methyl-1H-indol-3-yl)-1-[(4-chlorophenyl)methyl]-3-[(4-methylphenyl)sulfanyl]-5-oxo-N-(pyridin-2-ylmethyl)pyrrolidine-3-carboxamide. Compounds according to formula (I) are inhibitors of HDM2 and/or MDM2 and are useful for treating cancer and viral infections.
Patent NZ-596484-A (NZ)
Title: Chemokine receptor antagonists and methods of use thereof
Inventor: GHOSH SHOMIR
IPC: C07D221/00
Filed: 2002-11-13
Abstract: Disclosed herein is a pharmaceutical composition comprising the (S)-enantiomer and the (R)-enantiomer of 4-(4-chloro-phenyl)-1-{ 3-[7-(1-hydroxy-1-methyl-ethyl)-11H-10-oxa-1-azadibenzo[a,d]cyclohepten-5-ylidene]-propyl} -3,3-dimethyl-piperidin-4-ol or a physiologically acceptable salt thereof, wherein the ratio of (S)-enantiomer to (R)- enantiomer (w/w) in the composition is at least about 2:1. Said composition is useful in treating a disease associated with aberrant leukocyte recruitment, activation, or recruitment and activation such as: arthritis, atherosclerosis, arteriosclerosis, restenosis, ischemia/reperfusion injury, diabetes mellitus, psoriasis, multiple sclerosis, inflammatory bowel disease, rejection of a transplanted organ or tissue, graft versus host disease, allergy and asthma.
Patent NZ-597100-A (NZ)
Title: Transverse wedge connector
Inventor: HOXHA VLADIMIR
IPC: H01R4/50
Filed: 2010-07-22
Abstract: 597100 Disclosed is an electrical connector assembly (300) for mechanically and electrically connecting, or tapping, high voltage conductors (302, 304), or cables. The assembly includes a first conductive member (308) and a second conductive member (306). The first conductive member includes a first channel portion (352) extending from a first wedge portion (350), with the first channel portion configured to receive a first conductor therein. The first conductive member further includes a jaw (374) movably coupled to the first channel portion and is positioned between the first channel portion and the first wedge portion. Similarly, the second conductive member includes a second channel portion (312) extending from a second wedge portion (310), whereby the second channel portion is configured to receive a second conductor. The first wedge portion and the second wedge portion are assembled such that the second wedge portion engages the jaw and moves the jaw to the closed position. The jaw engages the first conductor in the closed position.
Patent NZ-600386-A (NZ)
Title: Improved oestrus detector
Inventor: ROBERTS JOCK MCDONALD
IPC: A01K21/00
Filed: 2010-11-30
Abstract: 600386 Disclosed is an oestrus detector for improved management of animal fertility and reproduction as part of a breeding programme. The detector includes a reservoir portion which contains a flowable substance; and the one or two indicator portions that is/are sealed from the reservoir portion, except for an open or closed passage in a seal line separating the reservoir portion from the rest of the detector. In use, a pressure upon the reservoir portion causes flowable substance to be squeezed through the passage and into a flow path in the at least one indicator portion where the flowable substance is visible. The flow path includes a series of compartments which will receive the flowable substance in a sequence. The second indication portion is attached to and sealed from the reservoir portion, except for a second open or closed passage in a second seal line separating the reservoir portion and the second indication portion.
Patent NZ-600723-A (NZ)
Title: Microwave vacuum-drying of organic materials
Inventor: FU JUN
IPC: F26B21/10
Filed: 2010-10-25
Abstract: An apparatus for dehydrating organic material such as food products and biologically-active materials such as vaccines, antibiotics, proteins and microorganism cultures using microwave vacuum-drying. The apparatus has (a) a vacuum chamber (34); (b) a set of two or more microwave generators (50); (c) a microwave-transparent window (36) for transmission of microwave radiation from the microwave generators (50) into the vacuum chamber (34); (d) a microwave chamber (52) between the microwave generators (50) and the microwave-transparent window (36), the two or more microwave generators (50) in the set being positioned such that a stream of microwaves from anyone generator (50) overlaps in the microwave chamber (52) with a stream of microwaves from any other generator (50) of the set; and (e) means for controlling the operation of the microwave generators (50) to repeatedly actuate and de-actuate the microwave generators (50) to cause interference between the stream of microwaves from any one generator (50) and the stream of microwaves from any other generator (50) of the set. The invention aims to permit enhanced control of the drying process by utilising the interference of microwaves so that the organic materials are treated uniformly.
Patent NZ-601689-A (NZ)
Title: Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms
Inventor: KAISER ASTRID
IPC: C07D237/32
Filed: 2011-03-01
Abstract: Disclosed are crystalline forms I and II of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, characterized by a disintegration temperature of greater or equal to 335 ± 10 degrees centigrade. Also disclosed is a method for producing the crystalline form I of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, characterized by mixing 5-amino-2,3-dihydrophthalazine-1,4-dione with sodium hydroxide solution and adding ethanol with a degree of purity ≥ 98% at room temperature within 10 – 40 minutes, thereby the solubility product of the generated 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt being reduced such that the latter precipitates, wherein the precipitated crystalline product is separated and dried at 50-90°C to produce crystalline form I, wherein crystalline form I is suspended several times in ethanol, stirred, rewashed with ethanol and again dried. Also disclosed is a method for producing crystalline form II of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, characterized by mixing 5-amino-2,3-dihydrophthalazine-1,4-dione with sodium hydroxide solution and adding 2-propanol at room temperature within 10 – 40 minutes, thereby the solubility product of the generated 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt being reduced such that the latter precipitates, wherein the precipitated crystalline product is separated and dried to produce crystalline form II.